Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Iron deficiency affects 30% of the world's population. Iron metabolism is tightly regulated, with both gut transport and storage being coordinated. Hereditary haemochromatosis due to mutations in the HFE gene leads to increased absorption of iron and multiple end-organ damage. Myelodysplastic disorders are acquired clonal stem-cell disorders that cause ineffective erythropoiesis. Aplastic anaemia is caused by an intrinsic defect of haemopoietic stem cells; both inherited and acquired forms occur. Primary polycythaemia is a myeloproliferative disorder, a non-malignant stem-cell disease.

Original publication

DOI

10.1016/S0140-6736(00)02099-7

Type

Journal article

Journal

Lancet

Publication Date

08/04/2000

Volume

355

Pages

1260 - 1268

Keywords

Anemia, Anemia, Aplastic, Anemia, Hemolytic, Anemia, Iron-Deficiency, Anemia, Macrocytic, Folic Acid Deficiency, Humans, Myelodysplastic Syndromes, Polycythemia, Vitamin B 12 Deficiency